Sahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. Prominent shareholders like Samara Capital and Kotak Pre-IPO Opportunities Fund will be offloading shares. A leading player in India’s drug-eluting stent market, SMT boasts a 25% market share. The company’s revenue increased to ₹1,024.
